News
New publication !
Innovhem proudly shares its latest scientific publication in Haematologica Journal, highlighting our commitment to advancing hematology research. In...
Aventure France 2030 !
Aventure France 2030 ! 🏆 Hier, à Paris, se tenait le Comité interministériel de l'innovation C2i. Nous sommes fiers de faire partie de...
🚨 Another step forward in the fight against sickle cell disease !
Another step forward in the fight against sickle cell disease ! On the occasion of the state visit to France by Their Majesties King Frederik X and...
Innovhem will present new data at the 2024 ASH Annual Meeting
Innovhem to present New data on single-cell quantification of HbF and HbS at the 2024 ASH Annual Meeting. One poster presentation to feature new...
Innovhem’s patents have been issued !
Innovhem's patents protect our BIOMARKERS : An important news ! SINGLE CELL QUANTIFICATION OF FETAL HEMOGLOBIN patent has been issued in France,...
Innovhem paticipates to HEMOPROVE study, sponsored by AP-HP
HEMOPROVE is an Open-label One Stage Phase II study sponsored by AP-HP. The investigator hypothesis is that the treatment by Voxelotor (GBT440) will...
Innovhem joins SISTA Entrepreneures
INNOVHEM is part of the 4th promotion of SISTA Entrepreneures with AXA FRANCE. This program aims to support the financing of companies run by women.
Innovhem joins the very first promotion of the french accelerator for digital health prevention
Innovhem is proud to be part of the first promotion of the french accelerator for digital health prevention ! BPI France and PariSanté Campus have...